Ora Medical Clinic（Berkeley, CA）
常见问题
How do GLP-1 Medications Work?
GLP-1 (Glucagon-Like Peptide-1) mimics the action of a naturally occurring peptide called glucagon-like peptide 1. This hormone is produced in the gut in response to food and stimulates the production of both glucagon and insulin to regulate blood sugar levels.
Who is GLP-1 not recommended for?
GLP-1s are not recommended for patients with a family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). They are also contraindicated in patients who are pregnant or breastfeeding.
What are common side effects for GLP-1 medications?
The most common side effects include nausea, vomiting, diarrhea, and constipation. Patients may experience fatigue or dizziness, particularly if they are not staying well hydrated or are following a severely calorie restricted diet.
What is Sarcopenia and how do GLP-1 affect it?
Sarcopenia, the loss of muscle mass, can occur with any form of severe calorie restricted diet not just those involving GLP-1 medications. Patients on GLP-1 therapy, especially postmenopausal women, are at increased risk of sarcopenia if their weight loss is not supported by regular exercise and adequate protein intake.
诊所简介
Ora Medical Clinic in Berkeley, CA offers telehealth weight management with Semaglutide, Tirzepatide, and metabolic health services across California and Was...
Ora Medical Clinic operates as a telehealth-focused medical practice serving patients throughout California and Washington, with board-certified internal medicine physicians providing evidence-based weight management and metabolic health services. The clinic specializes in treating metabolic syndrome, chronic disease management, and medically supervised weight loss through peptide therapies and comprehensive lifestyle interventions. Patients connect with providers remotely for initial consultations, ongoing monitoring, and treatment adjustments, eliminating the need for in-person visits while maintaining clinical rigor and personalized care protocols.
The clinic’s treatment protocols center on GLP-1 receptor agonists including Semaglutide and Tirzepatide for weight management and metabolic optimization, alongside Sermorelin for growth hormone support and NAD+ therapy for cellular metabolism enhancement. Semaglutide and Tirzepatide programs include dosage titration schedules tailored to individual tolerance and response patterns, with providers monitoring metabolic markers, body composition changes, and side effect profiles throughout treatment. Sermorelin protocols address age-related growth hormone decline and metabolic slowdown, while NAD+ infusion or supplementation supports mitochondrial function and energy metabolism in patients with chronic fatigue or metabolic dysfunction. Treatment plans integrate these peptide therapies with structured nutrition guidance, exercise programming, and behavioral modification strategies designed to address the root causes of metabolic disease rather than symptoms alone.
Ora Medical Clinic’s board-certified internal medicine physicians bring clinical training in chronic disease management, endocrine disorders, and preventive medicine to their telehealth practice model. The providers conduct comprehensive metabolic assessments including review of laboratory values, medication histories, comorbid conditions, and previous weight loss attempts before designing individualized treatment protocols. This internal medicine foundation allows the clinic to manage patients with complex medical histories including diabetes, hypertension, dyslipidemia, and fatty liver disease alongside their weight management goals. Providers emphasize shared decision-making and patient education, explaining the mechanisms of action for each peptide therapy, realistic outcome expectations, and the importance of lifestyle factors in achieving sustainable metabolic health improvements.
Patients beginning treatment at Ora Medical Clinic complete an initial telehealth consultation where providers review medical history, current medications, metabolic health markers, and weight management goals to determine appropriate peptide therapy candidates. Following the consultation, the clinic coordinates prescription fulfillment and provides detailed administration instructions for self-injectable medications, along with protocols for managing common side effects such as nausea or gastrointestinal changes during GLP-1 therapy initiation. Regular follow-up appointments occur via telehealth platform, allowing providers to review progress metrics, adjust medication dosages, address barriers to adherence, and modify nutrition or exercise recommendations based on patient response. The clinic’s approach combines the convenience of remote care delivery with the clinical oversight necessary for safe peptide therapy management and metabolic disease treatment.
The telehealth delivery model positions Ora Medical Clinic as an accessible option for California and Washington residents seeking specialized metabolic health care without geographic limitations or scheduling constraints associated with traditional clinic visits. Patients benefit from flexible appointment times, elimination of commute requirements, and the ability to maintain treatment continuity while traveling within licensed states. The clinic’s focus on evidence-based protocols, transparent communication about treatment mechanisms and expected outcomes, and integration of peptide therapies within comprehensive lifestyle medicine frameworks distinguishes its approach in the telehealth weight management space. With 16 patient reviews reflecting a 5.0-star rating and consistent mentions of provider knowledge, compassionate communication, and results-oriented care, Ora Medical Clinic has established a reputation for delivering clinical expertise and human-centered service in the Berkeley area and throughout its telehealth service regions.